PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
26-Jan-2022 InstaDeep Raises $100M to Scale Decision-Making AI Products that Solve Real-World Problems InstaDeep
26-Jan-2022 Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2021 Genmab
26-Jan-2022 Sareum to Participate in the Edison Group’s Global Healthcare “Open House” Virtual Conference (25-27 January 2022) Sareum Holdings plc
26-Jan-2022 ElmediX raises nearly 12 million euros to develop innovative heat technology to fight cancer ElmediX
26-Jan-2022 Cytovation raises $20 million in Series A financing round to advance clinical development of CyPep-1, a first-in-class targeted tumor membrane immunotherapy Cytovation AS
26-Jan-2022 TrakCel and Körber partner to provide orchestration within manufacturing of cell and gene therapies TrakCel
26-Jan-2022 CONFERENCE SERIES WIDENS INVESTOR ACCESS TO CUTTING-EDGE HEALTHCARE STOCKS Edison Group
26-Jan-2022 NICE EXPANDS GUIDANCE FOR LOKELMA®▼(sodium zirconium cyclosilicate) IN ADULT PATIENTS WITH PERSISTENT HYPERKALAEMIA AstraZeneca
26-Jan-2022 LoQus23 Therapeutics appoints Dr. Melanie Ivarsson, OBE, as Non-Executive Director LoQus23 Therapeutics
26-Jan-2022 OWEN MUMFORD ANNOUNCES ON MARKET RELEASE OF UNISAFE® 1mL SAFETY DEVICE FOR PRE-FILLED SYRINGES FEATURING INDUSTRY-FIRST SPRINGLESS MECHANISM Owen Mumford
26-Jan-2022 Verona Pharma Completes Enrollment in Phase 3 ENHANCE-2 Trial Evaluating Ensifentrine for Maintenance Treatment of COPD Verona Pharma
26-Jan-2022 Roche’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA) Roche
26-Jan-2022 Defence Therapeutics Inc.: Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9 Defence Therapeutics Inc.
26-Jan-2022 Queen’s University Belfast enters collaboration and licensing agreement with Ipsen to progress FLIP inhibitor project which has been supported by Domainex Sciad Newswire
26-Jan-2022 Xlife Sciences raises CHF 5.0 million through capital increase Xlife Sciences AG
26-Jan-2022 Lonza Delivers Strong 2021 performance with 20% CER Sales Growth Lonza Group AG
25-Jan-2022 Abivax 2022 Financial Communication Calendar ABIVAX
25-Jan-2022 FDA Grants Evrysdi® Priority Review Based on Results From Treating Pre-Symptomatic Infants with Spinal Muscular Atrophy PTC Therapeutics
25-Jan-2022 Biotage Launches TurboVap® 96 Dual Evaporator B3C newswire
25-Jan-2022 Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology Evotec SE